MariMed Inc. (MRMD) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
MariMed Reports Second Quarter 2022 Earnings
August 8, 2022 5:05 PM EDTNORWOOD, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (MariMed or the Company) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the second quarter ended June 30, 2022.
We executed on our strategic plan, growing revenue both year-over-year and sequentially, said Bob... More
